Foreign Manufacturing Facilities – Avoiding Problems with FDA 2012
29 Mar 2012
Webinar
Key Topics
Manufacturing in compliance with current good manufacturing practices (CGMP)
Findings of adulteration and creating new drugs – and resulting injunctions
Facilities and controls used for the manufacture, processing, packing, or holding of drugs
Meeting the quality and purity characteristics required by FDA
Keeping batch production and control records for each batch of drug product
Equipment cleaning and record keeping
Assessing the stability characteristics of drug products and determining appropriate drug storage conditions and expiration dates
Investigating unexplained discrepancy or the failure of a batch of drug products
Who should Attend
Hazard Analysis Critical Control Point (HACCP) Coordinators
Technical Directors / VP`s
Pharmaceutical Quality Assurance Managers
Pharmaceutical Operations / Production Managers
Past Events
Foreign Manufacturing Facilities – Avoiding Problems with FDA 2012 - 29 Mar 2012, Webinar (26437)
Foreign Manufacturing Facilities – Avoiding Problems with FDA 2026
Important
Please, check "Foreign Manufacturing Facilities – Avoiding Problems with FDA" official website for possible changes, before making any traveling arrangements
